joint diseases (McCarrel) Flashcards
1
Q
Major classes of joint disease
A
- Developmental orthopedic dz
- Traumatic/degenerative arthritis
- Septic arthritis
- Immune mediated polyarthritis
2
Q
End result of untreated joint dz
A
fuundamentally the same
3
Q
Horses don’t get what kind of arthritis
A
rheumatoid arthritis
4
Q
Developmental orthopedic dzs
A
- Osteochondrosis
- Osteochondritis dessicans
- Subchondral bone cysts
- can be traumatic in origin
- Delayed ossification
- part of angular limb deformity complex of DODs
5
Q
Traumatic/Degenerative osteoarthritis
A
- Chronic degeneration of joint tissues
- irreversible changes to the joint
- loss of function
- pain
6
Q
Tissuse changes in OA
A
- Synovitis
- primary or secondary
- primary is reversible
- primary or secondary
- Capsulitis
- may be reversible
- fibrosis => decreased ROM
- irreversible
- Ligamentous or meniscal injury
- joint instability
- Primary cartilage injury
- abnormal forces, normal cartilage
- intra-articular fracture
- normal forces on abdnormal cartilage
- wear and tear
- abnormal forces, normal cartilage
7
Q
Diagnosis of OA
A
- physical exam
- local anesthesia
- radiographs
- +/- ultrasound
- arthroscopy - gold standard
- nuclear scintigraphy
- computed tomograph
- magnetic resonance imaging
- synovial fluid analysis
8
Q
PE
CS
A
- Pain
- capsule, synovium, tendons, ligaments, periosteum, subchondral bone
- Synovial effusion
- Decreased ROM
- pain
- synovial effusion
- joint capsule fibrosis
- local inflammation (variable)
9
Q
DX OA
Local anesthesia
A
- Perineural
- Intra articular
10
Q
DX OA
Rads
A
- Rads
- enthtesiophytes
- osteophytes
- joint space narrowing
- subchondral bone sclerosis and/or lysis
- osteochondral fragments
11
Q
TX OA
Goals
A
- Multifocal approach
- Goals
- remove inciting cause
- slow progression of degeneration
- alleviate clinical signs
- restore function
- improve quality of life
- No cure for OA
12
Q
TX OA
considerations
A
- age
- size
- intended use
- temperament
- economics
13
Q
TX OA
A
- symptom modifying or disease modifying
- rest
- SX
- biology
- mechanics
- med therapy
- drugs
- biological therapies
- complimentary therapies
14
Q
Surgery for OA
Arthroscopy
A
- Arthroscopy - biology
- remove inciting cause
- fragment removal
- reduce articular fracture (mechanics)
- remove inflammatory mediators
- synovectomy?
- debridement
- repair stimulating techniques
- microfracture
- remove inciting cause
15
Q
Surgery for OA
cartilage repair
A
- Graft procedures
- osteochondral autograft or allograft
- mosac arthroplasty
- Chondrocyte transplantation (auto/allo)
- synthetic absorbably graft materials
- MSC graft
- PDS pins
- osteochondral autograft or allograft
16
Q
SX for OA
arthrodesis
facilitated ankylosis
A
- Arthrodesis
- mechanics
- surgical joint stabilization and fusion
- high motion joints - salvage
- low motion joints - althletic potential
- mechanics
- Ankylosis
- biology => mechanics
- procedures to hasten joint fusion
- surgical
- chemical
- laser
- low motion joints only
- procedures to hasten joint fusion
- biology => mechanics
17
Q
OA medical therapy
NSAIDS
A
- NSAIDS
- phenylbutazone
- flunixin meglumine
- firocoxib
- carprofen
- deracoxib
- etodolac
- meloxicam
18
Q
OA medical therapy
Corticosteroids
A
- intra articular use most common
- methylprednisolone acetate - low motion
- triamcinolone acetonide - high motion
- betamethasone
- isoflupredone
19
Q
Slow acting disease modifiers
examples
A
- hyaluronan
- Polysulphated glycosaminoglycan
- Pentosan polysulphate
20
Q
Hyaluronan
A
- hyaluronic acid, sodium hyaluronate
- IV and IA
- Lubrication
- Anti-inflammatory
- may upregulate endogenous production
- May have chondroprotective functions
21
Q
Polysulphated glycosaminoglycan
A
- Adequan
- IM and IA
- Increased risk of infection if used IA
- Stimulates endogenous hyaluronan synthesis
- Condroprotective effects
22
Q
Pentosan polysulphate
A
- Cartrophen
- IM
- Early OA only
- decreased fibrillation
23
Q
Biological therapy for OA
A
- IRAP or ACS
- PRP
- Stem cells
- MSC vs ASC
- IA injection or graft
- Gene therapy - experimental
- anabolic genes
- inhibitors of catabolic genes
24
Q
Complimentary therapies
A
- Physical therapy, swimming
- Hydrotherapy, ice, heat
- Massage
- Extracorporeal shock wave therapy
- Acupuncture
- Soft laser therapy
- Galvanic or faradic electrical stimulation
- Therapeutic ultrasound
- Counterirritants - blistering
25
Neutraceuticals
* Don't require FDA approval for safety and efficacy
* May include
* glucosamine
* Chondroitin sulfate
* ASU
* MSM
* Fatty acids
* Collagen
* Herbs
* Anti-oxidants
* Questionable quality
26
Septic arthritis
* Traumatic
* Iatrogenic
* Hematogenous
\***always an emergency**
27
Septic arthritis
Foals
* S-type
* synovial membrane and fluid
* E-type
* subchondral bone of epiphysis =\> extends into joint
* P-type
* physis
* may extend into joing
28
DX septic arthritis
* CS
* Radiographs
* Synovial fluid
* clinical pathology
* culture
* ultrasound (joint, primary source)
* advanced imaging
29
Septic arthritis
CS
* Lameness
* heat and swelling
* synovial effusion
* foals
* febrile
* primary septicemia
* physeal infection painful on palp
* +/- depression, inappetance
30
Septic arthritis
Rads
Chronic changes
* Rads
* rule out fracture
* bone involvement
* chronic changes
* joint space narrowing
* subchondral bone lysis
* caution foals
* periosteal proliferation
31
Synovial fluid culture
* Aerobic, anaerobic
* consider fungal if traumatic
* negative culture doesn't rule out infection
* collect sample prior to antibiotics
* still attempt if antibiotics have been started
* enrichment broth
* PCR
32
Synovial fluid culture
Cattle
Adult horse
Foal
* Cattle
* A pyogenes, strep, salmonella, E. coli, mycoplasma
* Adult horse
* staph aureus (iatrogenic)
* enteric gram negatives (trauma)
* Foal
* enterobacteriacea, strep, rhodococcus equi, actinobacillus equuli
33
**Clin path of synovial fluid**
**Septic arthritis**
* Appearance
* Color: anything other than straw colored is abnormal
* Clarity: anything besides clear is abnormal
* Viscosity: sticky is normal
* WBC
* \> 30,000 with \> 90% neutrophils
* degenerate neutrophils
* rarely see bacteria
* caution with very acute and very chronic cases
* TP \> 2g/dl
* +/- synovial fluid lactate: \> 4.9 mmol/L
* often no bacteria even in septic arthritis
34
Septic arthritis
TX
* Multimodal
* broad spectrum systemic antimicrobials
* synoval lavage
* intra-articular antimicrobials
* regional antibiotic perfusion
* bandage
* analgesia
* +/- arthrotomy
\***initiate therapy immediately, do not wait for culture results**
35
Synovial lavage
* Large volume BES
* DMSO
* General anesthesia vs standing
* Technique
* Arthoscopic
* chronic infection
* Bone involvement
* Traumatic injury - foreign material
* Large guage needle lavage
* often sufficient in acute cases
* switch to arthroscope if large amount of fibrin
36
Intra-artiular antibiotics
* Delivery
* intermittent: concentration dependent
* continuous: time dependent
* Results in highest antimicrobial conc in synovium
37
Regional Antibiotic perfusion
* Intravenous regional perfusion
* most common
* Intraosseous regional perfusion
* when vein is not accessible
* complications
* Place tourniquet for 30 minutes
* wide tourniquet, minimal movement
* Achieve very high concentrations locally
* less expensive
* avoid complications of systemic administration
38
Analgesia
* NSAIDS
* Opiates
* Continuous rate infusion
* Lidocaine
* Detomidine
* Butorphanol
* Ketamine
* Epidural catheter (hind limb)
* morphine and detomidine
* Bandage
39
Arthrotomy
* Rarely indicated
* Only very severe chronic cases that have not resolved using other methods
40
When to stop treatment
* Return of WBC count to normal is not an accurate guid
* Significant improvement in effusion and lameness
* **never** stop antimicrobials until
* lameness and effusion resolved
* substantially improved after removing
* drastically decreasing analgesic therapy
41
Immune mediated polyarthritis
* Primarily small animal
* Numerous causes
* idiopathic most common
* CS
* effusion of multiple joints
* pain
* lameness/stiffness
* may have other signs assoc with primary dz
42
DX immune mediated polyarthritis
* Three criteria
* **inflammatory process affecting synovium of two or more joints**
* **no identifiable infectious component**
* **responsive to immunosupressive therapy**
* Synovial fluid
* protein \> 2.5 g/dl
* NCC \> 3000 cells/ul
* **non-degenerate neutrophils** predominate
* not in all cases
* Radiography
* erosive vs nonerosive
* Tests to rule in/out primary disease process
43
Treatment Immune Mediated polyarthritis
* Treat underlying disease
* Immunosuppressants
* Immunomodulating drugs
\*No cookbook treatment plan